INTRACELLULAR EXPRESSION IN PIG CELLS OF ANTI-??1,3GALACTOSYLTRANSFERASE SINGLE-CHAIN FV ANTIBODIES REDUCES GAL??1,3GAL EXPRESSION AND INHIBITS CYTOTOXICITY MEDIATED BY ANTI-GAL XENOANTIBODIES1-Reference-Cited by-同舟云学术

INTRACELLULAR EXPRESSION IN PIG CELLS OF ANTI-??1,3GALACTOSYLTRANSFERASE SINGLE-CHAIN FV ANTIBODIES REDUCES GAL??1,3GAL EXPRESSION AND INHIBITS CYTOTOXICITY MEDIATED BY ANTI-GAL XENOANTIBODIES1

Published:1998-12 Issue:11 Volume:66 Page:1477-1485
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:Transplantation

Author:

Vanhove Bernard,Charreau Beatrice,Cassard Armelle,Pourcel Christine,Soulillou Jean-Paul

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference37 articles.

1. Interaction of the natural anti-Gal antibody with α-galactosyl epitopes: a major obstacle for xenotransplantation in humans

2. Simultaneous expression by porcine aorta endothelial cells of glycosphingolipids bearing the major epitope for human xenoreactive antibodies (Gal?1?3Gal), blood group H determinant andN-glycolylneuraminic acid

3. Characterization of porcine platelet glycoproteins recognized by human natural "anti-gal" antibodies

4. Enzymatic remodelling of the carbohydrate surface of a xenogenic cell substantially reduces human antibody binding and complement-mediated cytolysis

5. DOWN-REGULATION OF Gal??(1,3)Gal EXPRESSION BY ??1,2-FUCOSYLTRANSFERASE

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent Advances with ER Targeted Intrabodies;Advances in Experimental Medicine and Biology;2016

2. Recent Advances with ER Targeted Intrabodies;Protein Targeting Compounds;2015

3. With or Without Sugar? (A)glycosylation of Therapeutic Antibodies;Molecular Biotechnology;2012-10-25

4. Impact of Fc Glycosylation on Monoclonal Antibody Effector Functions and Degradation by Proteases;Current Trends in Monoclonal Antibody Development and Manufacturing;2009-10-10

5. Intracellular Antibodies (Intrabodies) and Their Therapeutic Potential;Therapeutic Antibodies;2008